Merial, Ltd., a prominent player in the animal health industry, operates its St. Louis Blending Facility in the United States, focusing on the development and production of anticoccidial products. Founded in the early 1990s, Merial has established itself as a leader in veterinary pharmaceuticals, particularly in the prevention and treatment of coccidiosis in livestock and poultry. With a commitment to innovation, Merial's core offerings include a range of anticoccidial solutions that are distinguished by their efficacy and safety profiles. The company has achieved significant milestones, including numerous regulatory approvals and partnerships that enhance its market position. Renowned for its dedication to animal welfare and sustainable practices, Merial continues to set industry standards, making it a trusted name among veterinarians and livestock producers alike.
How does Merial, Ltd., St. Louis Blending Facility and Anticoccidial Products Rights's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merial, Ltd., St. Louis Blending Facility and Anticoccidial Products Rights's score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merial, Ltd., St. Louis Blending Facility and Anticoccidial Products Rights currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the facility. As a merged entity, it is important to note that any potential emissions data or climate commitments may be cascaded from its parent organisation. However, no specific information regarding such data or commitments has been provided. In the context of the industry, it is essential for organisations like Merial to establish clear climate commitments and reduction targets to align with global sustainability goals. Without reported emissions or reduction initiatives, the facility's climate impact remains unclear, highlighting the need for enhanced transparency and accountability in its environmental practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merial, Ltd., St. Louis Blending Facility and Anticoccidial Products Rights has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

